ISSN: 1307-5888 | E-ISSN: 2757-7392 | Contact
Volume: 6 Issue: 3 Year: 2025
Copyright Transfer Form Author Contribution Form ICMJE COI Form
Submit an Article

Journal Metrics

2.2 CiteScore
2.1 Journal Impact Factor
Q3 JIF Quartile
05 days Submission to First Decision

Accepted Articles

1. The impact of long-term potent antiviral therapy on the natural course of disease in patients with hepatitis B virusrelated cirrhosis
Guner Kilic, Tugce Guvenir, Emin Bodakci, Zeynep Melekoglu Ellik, Hale Gokcan, Ramazan Idilman
DOI: 10.14744/hf.2024.2024.0069
Abstract Full Text PDF
2. Isolated IgG4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma: A case report and review
Gokalp Okut, Mehmet Alperen Ugur, Halil Yildiz, Birsen Gizem Ozamrak, Sait Murat Dogan
DOI: 10.14744/hf.2025.2025.0003
Abstract Full Text PDF
3. Duration of vasoconstrictors after endoscopic variceal ligation in acute variceal bleeding: A systematic review and network meta-analysis
Suprabhat Giri, Saurav Panda, Ankita Singh, Jijo Varghese, Sushrut Ingawale, Elliot B Tapper, Don C Rockey, Ashok Choudhury
DOI: 10.14744/hf.2025.82371
Abstract Full Text PDF
4. Role of micrornas in the pathophysiology and diagnosis of metabolic dysfunction-associated steatotic liver disease: A bibliometric review
Claudriana Locatelli, Tânia Beatriz Creczynski-Pasa
DOI: 10.14744/hf.2025.17142
Abstract Full Text PDF
5. Hepatic granulomas heralding eosinophilic granulomatosis with polyangiitis overlapping with Sjögren’s syndrome
Tayssir Ben Achour, Fatma Saïd, Abir Chérif, Maysam Jridi, Imed Ben Ghorbel, Ines Naceur, Monia Smiti
DOI: 10.14744/hf.2025.45561
Abstract Full Text PDF
6. Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction
Yusuf Yilmaz, Cem Simsek, Mete Ucdal, Eda Kaya
DOI: 10.14744/hf.2025.58577
Abstract Full Text PDF
7. A fructose-intolerant patient with acute liver injury: Not only the active ingredient, but also excipients matter
Eda Kaya, Aleko Zedginidze, Djawid, Baraksei, Ali Canbay, Andrea Tannapfel, Oliver Goetze
DOI: 10.14744/hf.2025.99427
Abstract Full Text PDF
8. A traditional herbal in liver diseases: Momordica charantia L. (kudret narı/bitter/bitter melon)
Dudu Altintas Gunduz, Yasemin Balaban, Ufuk Koca Caliskan
DOI: 10.14744/hf.2025.98035
Abstract Full Text PDF
9. Embolization of spontaneous portosystemic shunts for refractory hepatic encephalopathy in cirrhosis patients: A meta-analysis
Parth Patel, Mohamad Ebrahim, Eli Zaher, Himsikhar Khataniar, Priyadarshini Loganathan, Douglas G. Adler
DOI: 10.14744/hf.2025.59487
Abstract Full Text PDF
10. The effects of rifaximin on fructose-associated steatohepatitis: A study in a rat model
Neşe Çabuk Çelik, Rümeysa Yılmaz Göç, İbrahim Halil Bahçecioğlu, İ. Hanifi Özercan, Mehmet Tuzcu, Necip İlhan, Kazım Şahin
DOI: 10.14744/hf.2025.82889
Abstract Full Text PDF
11. Acute on chronic liver failure in erythropoietic protoporphyria: A case report and review of literature
Amith Viswanath, Rohan T Thomas, Santosh Kumar E, Uday George Zachariah, Sheethal K Jose, Meera Thomas, Thomas Alex Kodiatte
DOI: 10.14744/hf.2025.36953
Abstract Full Text PDF
12. Impact of statins on liver transaminases in patients with metabolic dysfunction–associated steatotic liver disease: A 12-month retrospective review
Paul Jen Wui Wong, Sau Chyun Ng, Samuel George, Rasnaizam bin Rasdi
Abstract Full Text PDF
13. Hepatic steatosis is associated with HBSAG seroclearance in patients with chronic hepatitis B virus infection but it is also associated with disease progression
Emin Bodakci, Saba Kiremitci, Zeynep Melekoglu Ellik, Ozge Koc, Mesut Gumussoy, Volkan Yilmaz, Sevinc Tugce Guvenir, Ramazan Erdem Er, Hale Gokcan, Berna Savas, Atilla Halil Erhan, Ramazan Idılman
DOI: 10.14744/hf.2025.74529
Abstract Full Text PDF
14. Role of insulin-like growth factor/receptor signaling in hepatocellular carcinoma
Sonia Bisht, Uma Sharma, Sangeetha Gupta
DOI: 10.14744/hf.2025.11358
Abstract Full Text PDF